Your browser doesn't support javascript.
loading
Next Generation Neuropeptide Y Receptor Small Molecule Agonists Inhibit Mosquito Biting Behavior.
Zeledon, Emely V; Baxt, Leigh A; Khan, Tanweer A; Michino, Mayako; Miller, Michael; Huggins, David J; Jiang, Caroline S; Vosshall, Leslie B; Duvall, Laura B.
Afiliação
  • Zeledon EV; Laboratory of Neurogenetics and Behavior, The Rockefeller University, New York NY 10065, USA.
  • Baxt LA; Howard Hughes Medical Institute, New York NY 10065, USA.
  • Khan TA; Sanders Tri-Institutional Therapeutics Discovery Institute, New York, New York 10065, USA.
  • Michino M; Sanders Tri-Institutional Therapeutics Discovery Institute, New York, New York 10065, USA.
  • Miller M; Sanders Tri-Institutional Therapeutics Discovery Institute, New York, New York 10065, USA.
  • Huggins DJ; Sanders Tri-Institutional Therapeutics Discovery Institute, New York, New York 10065, USA.
  • Jiang CS; Sanders Tri-Institutional Therapeutics Discovery Institute, New York, New York 10065, USA.
  • Vosshall LB; Department of Physiology and Biophysics, Weill Cornell Medicine, New York NY 10065, USA.
  • Duvall LB; Center for Clinical and Translational Science, The Rockefeller University, New York, NY 10065, USA.
bioRxiv ; 2024 Mar 05.
Article em En | MEDLINE | ID: mdl-38464241
ABSTRACT
Female Aedes aegypti mosquitoes can spread disease-causing pathogens when they bite humans to obtain blood nutrients required for egg production. Following a complete blood meal, host-seeking is suppressed until eggs are laid. Neuropeptide Y-like Receptor 7 (NPYLR7) plays a role in endogenous host-seeking suppression and previous work identified small molecule NPYLR7 agonists that suppress host-seeking and blood feeding when fed to mosquitoes at high micromolar doses. Using structure activity relationship analysis and structure-guided design we synthesized 128 compounds with similarity to known NPYLR7 agonists. Although in vitro potency (EC50) was not strictly predictive of in vivo effect, we identified 3 compounds that suppressed blood feeding from a live host when fed to mosquitoes at a 1 µM dose, a 100-fold improvement over the original reference compound. Exogenous activation of NPYLR7 represents an innovative vector control strategy to block mosquito biting behavior and prevent mosquito/human host interactions that lead to pathogen transmission.

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Idioma: En Revista: BioRxiv Ano de publicação: 2024 Tipo de documento: Article País de afiliação: Estados Unidos

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Idioma: En Revista: BioRxiv Ano de publicação: 2024 Tipo de documento: Article País de afiliação: Estados Unidos